🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Longitudinal Study of CRS/HIPEC for Peritoneal Carcinomatoses

Recruitingn/aAges 18 Years - 80 YearsAllUniversity of Regensburg
NCT04108936 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Longitudinal Study of the Effect of Cytoreductive Surgery and HIPEC in Patients With Peritoneal Carcinomatoses

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * suspicious peritoneal carcinomatosis Exclusion Criteria: * \<18 years
💊

What it tests

  • Not listed
📍

Where

2 sites
Krankenhaus der Barmherzigen Brüder Regensburg
Regensburg, Germany
University Hospital Regensburg
Regensburg, Germany
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy